Technology Prognosis

tracking technologies before you have to make a decision

Prognosis is a horizon scanning service that monitors emerging health technologies as they go through clinical trial development and the regulatory approval process.

View a sampling of our Prognosis reports.

OTX-DP (Possible Name: Dextenza)

February 16, 2017 Technology Prognosis

A sustained-release dexamethasone hydrogel punctum plug proposed as an alternative to steroid eye drops for the treatment of ocular pain after ophthalmic surgery.

Tecentriq (Atezolizumab) for Urothelial Carcinoma

February 14, 2017 Technology Prognosis

An intravenous programmed death ligand 1 checkpoint inhibitor for treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy, and for patients who have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.    

Eversense Continuous Glucose Monitor

February 10, 2017 Technology Prognosis

An investigational continuous glucose monitor with implantable sensor for management of diabetes mellitus in adult patients who use insulin.

Tecentriq (Atezolizumab) for Non-Small Cell Lung Cancer

February 8, 2017 Technology Prognosis

A programmed death-ligand 1 checkpoint inhibitor to treat locally advanced or metastatic non-small cell lung cancer.

Sentinel Cerebral Protection System (CPS)

February 3, 2017 Technology Prognosis

A dual filter cerebral embolic protection device for use during transcatheter aortic valve replacement (TAVR).